tiprankstipranks
Trending News
More News >
Humacyte (HUMA)
NASDAQ:HUMA
US Market

Compare Humacyte (HUMA) vs. Competitors

Compare
1,591 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Humacyte
$1.19
$223.88M
-61.46%
3 Buy
0 Hold
0 Sell
Strong Buy
Cartesian Therapeutics
$7.18
$190.33M
-1.44
-50.28%
5 Buy
1 Hold
0 Sell
Strong Buy
Allogene Therapeutics
$2.27
$553.38M
22.70%
9 Buy
0 Hold
0 Sell
Strong Buy
Foghorn Therapeutics
$5.06
$297.02M
-4.58
10.00%
7 Buy
0 Hold
0 Sell
Strong Buy
Kyverna Therapeutics, Inc.
$8.95
$502.74M
-1.77
246.46%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HUMA
Humacyte
1.16
-2.15
-64.95%
RNAC
Cartesian Therapeutics
7.18
-8.28
-53.56%
ALLO
Allogene Therapeutics
2.27
0.58
34.32%
IMAB
FHTX
Foghorn Therapeutics
5.06
0.62
13.96%
KYTX
Kyverna Therapeutics, Inc.
8.80
6.43
271.31%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts